COMPASS: Mortality benefit of rivaroxaban plus aspirin in patients with chronic coronary or peripheral artery disease
Journal of the American College of Cardiology
JW Eikelboom, DL Bhatt, KAA Fox, J Bosch, SJ Connolly, SS Anand, A Avezum, SD Berkowitz, KRH Branch, GR Dagenais, C Felix, TJ Guzik, RG Hart, AP Maggioni, E Muehlhofer, M Sharma, O Shestakovska, S Yusuf
June 2021